Amp Capital Investors LTD Ionis Pharmaceuticals Inc Transaction History

Amp Capital Investors LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $1.08 Million - $1.48 Million	-31,333 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $19,074 - $25,305	402 Added 1.3%	31,333 $1.52 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $796 - $1,037	-17 Reduced 0.05%	30,931 $1.84 Million
Q1 2020 May 13, 2020	SELL	$41.6 - $63.4 $465,670 - $709,699	-11,194 Reduced 26.56%	30,948 $1.49 Million
Q4 2019 Feb 13, 2020	SELL	$53.85 - $65.27 $1.55 Million - $1.88 Million	-28,832 Reduced 40.62%	42,142 $2.54 Million
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $2.63 Million - $3.21 Million	44,513 Added 168.22%	70,974 $4.19 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $1.64 Million - $2.28 Million	26,461 New	26,461 $1.71 Million

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.03B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.